|
|
SIXTH ASIA PACIFIC
PHARMACEUTICAL AND
MEDICAL DEVICE
COMPLIANCE CONGRESS
ATTEND ONSITE
September 21 - 23, 2016
Shangri-La Hotel, Singapore
|
|
KEYNOTE SPEAKERS
|
Charles Cain, JD
Deputy Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC |
Graeme Gunn
Legal Analyst and Manager China Outreach, Anti-Corruption Division, OECD; Former Senior Legal Officer, Attorney-General's Department, Australia, Paris, France |
Ben Morgan
Joint Head of Bribery and Corruption, UK Serious Fraud Office, London, UK
|
Sophie Peresson, LLM, MA
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, London, UK |
Jean-Christophe Pointeau, CEDEP INSEAD
General Manager Pharma, Sanofi China, Vice Chairman, RDPAC-China, Former General Manager, BMS China, Former General Manager, BMS Poland, Shanghai, China |
Neill Stansbury, Esq.
Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK
|
|
|
KEYNOTE GLOBAL CHIEF COMPLIANCE OFFICER ROUNDTABLE
|
Dante Beccaria
Senior Vice President, Global Ethics & Business Integrity, Sanofi, Vice Chair, Code Committee Network, IFPMA, Paris, France |
Sujata Dayal, Esq.
Vice President Health Care Compliance and Privacy, Pharmaceuticals, Johnson & Johnson, Titusville, NJ, USA |
Anne Nielsen, JD, LLM
Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, Chair, Code Committee Network, IFPMA, New York, NY, USA
|
Caroline West
Global Chief Compliance Officer, Olympus Corporation; Former Senior Vice President, Chief Compliance and Risk Officer, Shire, Philadelphia, PA, USA |
Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator)
|
|
|
FEATURING PRECONFERENCE SESSIONS
|
- Compliance 101 Workshop
- Use of Analytics to Manage Risks and Detect Fraud
|
|
PLENARY SESSIONS
|
- C-Suite Keynote Address
- Global Compliance Officer Roundtable
- Transparency International Keynote
- UK Serious Fraud Office Update
- US Securities and Exchange Commission Update
- The ISO 37001 Anti-Bribery Management Systems Standard
- Asia Pac Regional Regulatory and Enforcement Roundtable
- Asia Pac Compliance Code and APEC Principles Updates
- Optimizing the Relationship with Third Parties
- Best Practices in Medical Affairs Compliance
- Life Sciences Compliance Challenge: Moving from Cost to Value
- Roundtable on Creating an Ethical Culture
|
|
|
|
AND MINI SUMMITS
|
- China, Hong Kong and Taiwan Compliance Roundtable
- India Compliance Roundtable
- Innovation in Compliance
- Patient Support Programs Compliance Issues
- Transactions, Partnerships and M&A Compliance Issues
- Asia Pac Medical Device Compliance Roundtable
- Promotional and Incentive Programs Compliance Issues
- Asia Pac Transparency and Disclosure Updates
- Research and Development Compliance Issues
|
|
ASIA PACIFIC PHARMA CONGRESS IS
|
|
|
|
|
FEATURED FACULTY
|
Dr. Milind Antani, MBBS, LLB
Partner in charge-Pharma & Healthcare Practice, Nishith Desai Associates, Mumbai, India |
Eric Carlson, Esq.
Partner, Covington & Burling LLP, Contributing Editor, FCPA Blog, Shanghai, China |
Stacy Chai
Director, Fraud Investigation & Dispute Services, EY, Singapore
|
Sabrina S. K. Chan, MA, JD
Executive Director, The Hong Kong Association of the Pharmaceutical Industry (HKAPI), Hong Kong |
Tom Chan, JD, LLM
Head of Legal, Greater China, Takeda (China) Holdings Co. Ltd, Shanghai, China |
Chi Chen, MS
Partner, EY, Shanghai, China
|
Eugene Chen, Esq.
Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China |
Yoo-Kyung (Karen) Choi, JD, LLM
Japan and Korea Compliance Lead, Pfizer, Seoul, Korea |
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
|
Adam Dryburgh LLB, Dip LP, LLM
Associate, White Collar and Fraud Group, Hogan Lovells, Singapore |
Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA |
Marc Eigner, MS, MBA
Senior Partner, Co-Founder and Head of the Technology Solutions, Polaris Solutions, New York, NY, USA
|
Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China |
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Singapore |
Don Ferrin, PhD
Professor of Organisational Behaviour and Human Resources, Singapore Management University, Singapore
|
Andrew Frye, MBA
Global Head, Business Unit Healthcare, Member of Group Management, DKSH (Thailand) Ltd, Bangkok, Thailand |
Ramon Ghosh
Director, CFI, Control Risks, Singapore |
Gary Giampetruzzi, Esq.
Partner, Paul Hastings; Former Vice President and Assistant General Counsel and Head, Government Investigations, Pfizer Inc., Washington, DC, USA
|
Mohit Grover
Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore |
Andrew Ho
Head of Ethics and Business Integrity, Australia and New Zealand, Sanofi, Former Compliance Associate, Novartis, Macquarie Park NSW, Australia |
David Hodgson
Partner and Audit Advisory Global Lead, Deloitte, London, UK
|
Ewa Holker, JD
Head of Legal & Compliance, Asia Pacific, Ferring, Singapore |
Rajiv Joshi, ICAI, ISACA, CIA, CFE
Partner, Fraud Investigation & Dispute Services, EY, Mumbai, India |
Casey Kah
Partner, EY, Shanghai, China
|
Hancheol Kang, LLB, LLM
Senior Attorney, Health Group, Kim & Chang Law Firm, Seoul, South Korea |
Jasmine Karimi, LLM
Senior Director and Counsel, APAC, Illumina, Former President, Hong Kong Corporate Counsel Association, Singapore |
Reuben Khoo, MBA
Managing Partner, FIDS ASEAN, Head of Forensic Technology & Discovery Services Asia Pacific, EY, Singapore
|
Christopher E. Knight, JD
Senior Executive Advisor, Pharmaceutical Research and Manufacturers Association Thailand (PReMA), Chief Executive Officer, Everett Knight (Asia Pacific) Pte Ltd., Singapore |
Sarah Kochling
Managing Principal, Blossom Consultancy Ltd., Shanghai, China |
Katsumi Kojima
Head of Ethics and Business Integrity, Japan, Sanofi Japan Group, Tokyo, Japan
|
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA |
Benjamin Kwak, JD
Vice President, Compliance Officer and Senior Legal Counsel (Asia Pacific), Zimmer Biomet, Singapore |
Henry J. Li
Legal Director and General Counsel, R&D Based Pharmaceutical Association Committee, Beijing, China
|
Lei Li, LLM
Partner, Sidley Austin, Former Third Secretary, Ministry of Commerce, People's Republic of China, Beijing, China |
Abdul Luheshi, MBA
Director, Life Sciences Regulatory Compliance, KPMG, Former Vice President, Health Care Compliance, Johnson & Johnson, Founding Co-chair, Asia Pacific Pharma Compliance Congress, London, UK |
Andrew Martin
Principal and Head of Corporate & Securities, Baker & McKenzie, Wong & Leow, Singapore
|
Timothy J. McGuire, MBA
Director, Global HCP Transparency Reporting, Eli Lilly and Company, Indianapolis, IN |
David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles; Board Member, ETHICS; Former Vice President Compliance, International Pharmaceuticals, GSK; Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK |
Alison Parkes, PhD
Vice President Compliance Emerging Markets and APAC, Smith & Nephew, Singapore
|
Kent Phillips
Partner, Hogan Lovells Lee & Lee, Singapore |
Redentor Romero, JD
Associate Director, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel, AstraZeneca, Singapore |
Yee Chung Seck, Esq.
Partner and Lead, Pharmaceutical and Healthcare Practices, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam
|
Sandeep Seth
Compliance Director, India, Pfizer; Former Director, Compliance, MSD Pharmaceuticals Pvt. Ltd., Mumbai, India |
Clarissa Shen, MBA
Vice President, Head of Ethics and Business Integrity, Sanofi Group - China; Former Associate Compliance Director, Eli Lilly Asia Inc.; Former Acting Compliance Head, BMS China, Shanghai, China |
Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore
|
Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics / Compliance / Legal / Sustainability), Legal/International Compliance and Risk Management Professional, , Singapore and Delhi, India |
Belinda Tan
Partner, Fraud Investigations & Dispute Resolutions, EY, Singapore |
Boon Heon Tan, MSE
Managing Director, South East Asia and Korea, UCB, Hong Kong, China
|
Yuet Ming Tham, JD
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong |
Albert van Maaren, MSc
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore |
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Lead, Pfizer, Hong Kong
|
Mark Wanda, JD
Executive Director, Anti-Bribery/Anti-Corruption Compliance, Astellas US LLC, Former Sr. VP, Legal Affairs and GC, Sunovion, Former Sr. VP and Deputy GC, Sepracor, Chicago, IL, USA |
Chae Sing Wong
Head of Regional Compliance (APAC, MEA, LATM), Mundipharma Pte Ltd; Former Compliance Director, Asia, ANZ and Japan, Baxalta; Former Compliance Director Asia Area, AstraZeneca, Singapore |
Sow Wei Wong
Legal Counsel Research and Development Centre, at Takeda Global (Asia) Pte Ltd, Former Senior Compliance Counsel, Allergan, Singapore
|
Vivian W. Wu, LLB, LLM
Partner, Baker & McKenzie, Beijing, China |
Jooha Yang
Regional Compliance Manager, Roche Pharma Asia Pacific, Singapore |
Qi (Aaron) Yao, MA
Compliance Manager, Cordis, Former Associate Manager, Compliance, Roche, Shanghai, China
|
Riza Faith Ybanez, LLB
Legal and Compliance Head - Oncology Asia Pacific, South Africa, Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore |
Mike Zhao
Head, Compliance China, UCB Pharma, Shanghai, China
|
|
|
|
|
SPONSORED BY:
|
|
The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.
|
|
COSPONSORED BY:
|
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
CO CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore
|
Maija Burtmanis, LLB/BSc LLM
Healthcare Compliance Officer, Asia Pacific Medical Sciences, Johnson & Johnson, Former Associate General Counsel, Alcon Russia, Former Asia Pacific, Country Compliance Officer, Novartis SG, Singapore
|
Gareth Lee
Vice President, Legal and Compliance, Asia Pacific, Cardinal Health, Former General Counsel & Head of Compliance, Asia Pacific, Allergan, Singapore
|
Maria "Maru" Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
|
Rhys Tee
Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
CONTINUING EDUCATION CREDITS
|
- Accounting Professionals: Approved for up to 18 NASBE CPE credits.
- Compliance Professionals: Approved for up to 24 Compliance Certification Board CCB credits.
- Attorneys: Approved for up to 13.5 Pennsylvania MCLE credits.
Click here for more information.
|
|
2016 ASIA PAC CONGRESS PLANNING COMMITTEE
|
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Former VP, Chief Compliance Officer, Dendreon, Former Associate General Counsel and Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA
Hwa-Soo Chung, Esq.
Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
Jill Dailey, JD, MBA
Assistant General Counsel, Asia Pacific Compliance Lead, Pfizer, New York, NY, USA
Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA
Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International Asia, Singapore
Emmanuelle Ferrari, MBL
Head of Legal and Compliance APAC, Sandoz, Former Senior Legal Counsel, Novartis Vaccines and Diagnostics, Singapore
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
Mohit Grover
Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore
Ewa Holker, JD
Head of Legal & Compliance, Asia Pacific, Ferring, Singapore
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Patrik Kronig
Head of Compliance Asia Pacific, Roche, Basel, Switzerland
Cristopher Landrito, LIB
Area Compliance Officer, APAC, Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd. Inc., Former Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore
David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles; Board Member, ETHICS; Former Vice President Compliance, International Pharmaceuticals, GSK; Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK
Katrina Reinhardt, JD
Regional Head Ethics and Compliance, Asia Pacific, Baxter Healthcare, Singapore
Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International, Former Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel - Southeast Asia & Taiwan, AstraZeneca Pharmaceuticals, Singapore
Carol Shi
Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore
Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/Sustainability), Legal/International Compliance and Risk Management Professional, Former Vice President and Compliance Officer, Pharma, EJEMAP, GSK, Former Director, Compliance, APAC, Abbott Labs, Singapore and Delhi, India
Yuet Ming Tham, JD
Partner, Sidley Austin LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong
Albert van Maaren
Regional Compliance Officer APAC, Group Compliance, Merck Pte. Ltd., Singapore
Emmanuel Vignal
Partner, Fraud Investigation & Dispute Services, EY, Shanghai, China
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Lead, Pfizer, Hong Kong
Genevieve Wan
Asia-Pacific Pharmaceuticals Compliance Officer, GlaxoSmithKline, Singapore
Riza Faith Ybanez, LLB
Head of Legal and Compliance, Oncology, Asia Pacific, Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Former Asia Cluster Compliance Lead, Novartis, Singapore
|
|
FOLLOW ASIA PACIFIC PHARMA CONGRESS ON
|
|
|
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
|
|
|
SIXTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
September 21 - 23, 2016
|
ATTEND ONSITE
Shangri-La Hotel
Singapore
|
|
|
